← Open Payments lookup

MICHELLE FISH: Open Payments

NPI 1104341684 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$597 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $634 · 2025 $597

Food & beverage: $597
CompanyPaymentsAmount
ABBVIE INC.2$137
Regeneron Pharmaceuticals, Inc.1$124
Boston Scientific Corporation1$117
Janssen Biotech, Inc.4$88
Takeda Pharmaceuticals U.S.A., Inc.3$62
GENZYME CORPORATION1$42
Ferring Pharmaceuticals Inc.1$27

Products named: DUPIXENT, WallFlex Duodenal, TREMFYA, ENTYVIO, REBYOTA, LINZESS.

Industry payments across IN — which companies pay providers there.